Produktname:4-bromo-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile

IUPAC Name:4-bromo-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile

CAS:2068065-05-2
Molekulare Formel:C8H4BrN3O
Reinheit:95%+
Katalognummer:CM325559
Molekulargewicht:238.04

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM325559-100mg in stock Ⱥƿ
CM325559-250mg in stock ƿȺŵ
CM325559-1g in stock ŵȺƎ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:2068065-05-2
Molekulare Formel:C8H4BrN3O
Schmelzpunkt:-
SMILES-Code:N#CC1=C2C(Br)=CC(O)=CN2N=C1
Dichte:
Katalognummer:CM325559
Molekulargewicht:238.04
Siedepunkt:
Mdl-Nr.:
Lagerung:

Category Infos

Pyrazolopyridines
Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.

Column Infos

Selpercatinib
The FDA has granted accelerated approval to selpercatinib (Retevmo; Eli Lilly and Company) for pediatric patients aged 2 years and older with RET-altered metastatic thyroid cancer or solid tumors, the federal agency announced in a press release. Selpercatinib is a highly selective, potent RET inhibitor. It works by blocking a type of enzyme (kinase) and helps prevent the cancer cells from growing.

Related Products